Replies to post #2567 on Nascent Biotech Inc. (NBIO)

[BlazingStocks]

Thanks for sharing that link to Seeking Alpha...

The patent will be issued on Nov. 8.
"This issuance strengthens our growing IP portfolio in our brain cancer treatment using Pritumumab, a unique natural antibody that crosses the blood brain barrier," said Nascent CEO Sean Carrick.